MK0594
0594-003
Phase 2 small_molecule completed
Quick answer
MK0594 for Urinary Incontinence is a Phase 2 program (small_molecule) at VYNE Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VYNE Therapeutics
- Indication
- Urinary Incontinence
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed